-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

Benzinga·09/21/2026 12:07:44
语音播报
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.